Abstract
Diagnosis on myocardial ischemia is often difficult. The ischemia-modified albumin (IMA) assay presents a quantitative accurate laboratory determination of the occurrence of an iscbemic myocardial event. Unlike previous serum items that identify myocardial damage after the event, this test allows doctors to determine which patient has potential coronary artery lesions before occlusion occurs. Albumin cobalt binding (ACB) test is the assay that measures IMA in human serum, and may be used as an early marker of myocardial iscbemia that occurs prior to myocardial necrosis. Key words: ischemia-modified albumin; albumin cobalt binding test; myocardial ischemia
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
